111
|
|
|
Potassium sodium-activated channel subfamily T member 1 |
DEE14, EIEE14, ENFL5, KCa4.1, KNa1.1, SLACK, Slo2.2, bA100C15.2 |
Nocturnal frontal lobe epilepsy, Childhood-onset epilepsy syndrome, Color vision deficiency, Colorectal cancer, Developmental and epileptic encephalopathy, Developmental disability, Partial epilepsy, Epilepsy of infancy with migrating focal seizures, Frontal lobe epilepsy, Rolandic epilepsy, Gastrointestinal disease, Hydrocephalus, Malignant migrating partial seizures of infancy, Neurodevelopmental disorder, Schizophrenia, ScoliosisView all (1 more) |
112
|
|
|
Potassium sodium-activated channel subfamily T member 2 |
DEE57, EIEE57, KCa4.2, KNa1.2, SLICK, SLO2.1 |
|
113
|
|
|
Potassium calcium-activated channel subfamily U member 1 |
KCNMC1, KCa5, KCa5.1, Kcnma3, SPGF79, Slo3 |
Attention deficit hyperactivity disorder, Bipolar disorder, Breast cancer, Contracture, Corneal astigmatism, Diabetes mellitus, Diabetes mellitus type 2, Estrogen-receptor negative breast cancer, Gastric cancer, Schizophrenia, Spermatogenic failure, Substance abuse |
114
|
|
|
Potassium voltage-gated channel modifier subfamily V member 1 |
HNKA, KCNB3, KV2.3, KV8.1 |
|
115
|
|
|
Potassium voltage-gated channel modifier subfamily V member 2 |
KV11.1, Kv8.2, RCD3B |
|
116
|
|
|
Kielin cysteine rich BMP regulator |
CRIM2, KCP1, NET67 |
|
117
|
|
|
Potassium channel tetramerization domain containing 1 |
C18orf5 |
|
118
|
|
|
Potassium channel tetramerization domain containing 10 |
BTBD28, MSTP028, ULRO61, hBACURD3 |
|
119
|
|
|
Potassium channel tetramerization domain containing 12 |
C13orf2, PFET1, PFETIN |
|
120
|
|
|
Potassium channel tetramerization domain containing 14 |
- |
|